Pituitary Insulin-Like Growth Factors

Endocrine Pathology

Volumn 8, Issue 3, 1997, Pages 167-179

  Yokoyama, Shunichi ^a   Stefaneanu, Lucia ^b   Kovacs, Kalman ^b  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

IGF I; IGF II; Neoplasm; Pituitary

Indexed keywords

EID: 0004961253     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02738783     Document Type: Review

References (98)

1. Rinderknecht E, Humbel RE. The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem 253:2769-2776, 1978.
2. Rinderknecht E, Humbel RE. Primary structure of human insulin-like growth factor II. FEBS Lett 89:283-286, 1978.
3. Giudice LC, De Zegher F, Gargosky SE, Dsupin BA, De Las Fuentes L, Crystal RA, Hintz RL, Rosenfeld RG. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab 80:1548-1555, 1995.
4. Daughaday WH, Rotwein P. Insulin-like growth factors-I and -II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 10:68-90, 1989.
5. Schwander JC, Hauri C, Zapf J, Froesch ER. Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: dependence on growth hormone status. Endocrinology 113:297-305, 1983.
6. D'Ercole AJ, Stiles AD, Underwood LE. Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanism of action. Proc Natl Acad Sci USA 81:935-939, 1984.
7. Lahm H, Amstad P, Wyniger J, Vilmaz A, Fischer JR, Schreyer M, Givel JC. Blockade of the insulin-like growth -factor-I receptor inhibits growth of human colorectal cancer cells: evidence of a functional IGF-II-mediated autocrine loop. Int J Cancer 58:452-459, 1994.
8. Sullivan KA, Castle VP, Hanash SM, Feldman EL. Insulin-like growth factor II in the pathogenesis of human neuroblastoma. Am J Pathol 147:1790-1798, 1995.
9. DeChiara TM, Robertson EJ, Efstratiadis A. Parental imprinting of the mouse insulin-like growth factor II gene. Cell 64:849-859, 1991.
10. Valentinis B, Bhala A, DeAngelis T, Baserga R, Cohen P. The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol Endocrinol 9:361-367, 1995.
11. Bach MA, Bondy CA. Anatomy of the pituitary insulin-like growth factor system. Endocrinology 131 2588-2594, 1992.
12. Booth BA, Bar SR, Boes M, Dake BL, Bayne M, Cascieri M. Intrinsic bioactivity of insulin-like growth factor binding proteins from vascular endothelial cells. Endocrinology 127:2630-2638, 1990.
13. Hill DJ, Clemmons DR, Wilson S, Han VK, Strain AJ, Milner RD. Immunological distribution of one form of insulin-like growth factor(IGF)-binding protein and IGF peptides inhuman fetal tissues. J Mol Endocrinol 2:31-38, 1989.
14. De Leon DD, Wilson DM, Powers M, Rosenfeld RG. Effects of insulin-like growth factors (IGFs) and IGF receptor antibodies on the proliferation of human breast cancer cells. Growth Factors 6:327-336, 1992.
15. Andersson I, Billig H, Fryklund L, Hansson HA, Isakason O, Isagaard J, Nilsson A, Rozell B, Skottner A, Stemme S. Localization of IGF-I in adult rats. Immunohistochemical studies. Acta Physiol Scand 126:311,312, 1986.
16. Edmondson SR, Werther GA, Russell A, LeRoith D, Roberts CT Jr, Beck F. Localization of growth hormone receptor/binding protein messenger ribonucleic acid (mRNA) during rat fetal development: relationship to insulin-like growth factor-I mRNA. Endocrinology 136:4602-4609, 1995.
17. Stefaneanu L, Kovacs K. Adenohypophysial morphology in transgenic dwarf mice with cerebral production of human growth hormone. Acta Anat 152:19-27, 1995.
18. Wood TL. Gene-targeting and transgenic approaches to IGF and IGF binding protein function. Am J Physiol 269(4 Pt 1):E613-622, 1995.
19. Aguado F, Fernández T, Martinez-Murillo R, Rodrigo J, Cacicedo L, Sánchez-Franco F. Immunocytochemical localization of insulin-like growth factor I in the hypothalamo-hypophyseal system of the adult rat. Neuroendocrinology 56:856-863, 1992.
20. Lü F, Yang K, Han VKM, Challis JRG. Expression, distribution, regulation and function of IGFs in the ovine fetal pituitary. J Mol Endocrinol 14:323-336, 1995.
21. Lee WH, Bowsher RR, Apathy JM, Smith MC, Henry DP. Measurement of insulin-like growth factor-II in physiological fluids and tissues. II. Extraction and quantification in rat tissues. Endocrinology 128:815-822, 1991.
22. Goodyer CG, De Stephano L, Lai WH, Guyda HJ, Posner BI. Characterization of insulin-like growth factor receptors in rat anterior pituitary, hypothalamus, and brain. Endocrinology 114:1187-1195, 1984.
23. Rosenfeld RG, Ceda G, Wilson DM, Dollar LA, Hoffman AR. Characterization of high affinity receptors for insulin-like growth factors I and II on rat anterior pituitary cells. Endocrinology 114:1571-1575, 1984.
24. Ocrant I, Valentino KL, Hoffman AR, Hintz RL, Wilson DM, Rosenfeld RG. Structural characterization and immunohistochemical localization of receptors for insulin-like growth factor II in the rat pituitary gland. Neuroendocrinology 49:248-254, 1989.
25. Enjoh T, Hizuka N, Perdue JF, Takano K, Fujiwara H, Higashihashi N, Marumoto Y, Fukuda I, Sakano K. Characterization of new monoclonal antibodies to human insulin-like growth factor-II and their application in western immunoblot analysis. J Clin Endocrinol Metab 77:510-517, 1993.
26. Alberti VN, Takita LC, de Mesquita MI, Percario S, Maciel RM. Immunohistochemical demonstration of insulin-like growth factor I (IGF-I) in normal and pathological human pituitary gland. Pathol Res Pract 187:541,542, 1991.
27. Haselbacher GK, Schwab ME, Pasi A, Humbel RE. Insulin-like growth factor II (IGF II) in human brain: regional distribution of IGF II and of higher molecular mass forms. Proc Natl Acad Sci USA 82:2153-2157, 1985.
28. Huang ZH, Clayton PE, Brady G, Morris ID. Insulin-like growth factor-I gene expression in human granulosa-lutein cells. J Mol Endocrinol 12:283-291, 1994.
29. Stefaneanu L, Thapar K, Kovacs K. In situ hybridization study of insulin-like growth factor-I mRNA in human pituitary adenomas. J Surg Pathol, Abstracts, 2(Suppl Jan.), Abstract nr182, 1995.
30. Fagin JA, Pixley S, Slanina S, Ong J, Melmed S. Insulin-like growth factor I gene expression in GH3 rat pituitary cells: messenger ribonucleic acid content, immunocytochemistry, and secretion. Endocrinology 120:2037-2043, 1987.
31. Baccarini P, Fiorentino M, D'Errico A, Mancini AM, Grigioni WF. Detection of anti-sense transcripts of the insulin-like growth factor-2 gene in Wilms' tumor. Am J Pathol 143:1535-1542, 1993.
32. Glick RP, Unterman TG. Radioimmunoassay of insulin-like growth factors I and II in the cerebrospinal fluid of patients with pituitary and other central nervous system tumors. Neurosurgery 36:556-564, 1995.
33. Zumkeller W, Sääf M, Rähn T, Hall K. Demonstration of insulin-like growth factors I, II and heterogenous insulin-like growth factor binding proteins in the cyst fluid of patients with craniopharyngioma. Neuroendocrinology 54:196-201, 1991.
34. Stylianopoulou F, Efstratiadis A, Herbert J, Pintar J. Pattern of the insulin-like growth factor II gene expression during rat embryogenesis. Development 103:497-506, 1988.
35. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (IgF-I) and type I IGF receptor (IgF-Ir). Cell 75:59-72, 1993.
36. Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, Gillett N, Stewart TA. IGF-I is required for normal embryonic growth in mice. Genes Dev 7:2609-2617, 1993.
37. Stefaneanu L, Powell-Baxton L, Kovacs K, Tampanaru A. Adenohypophysial morphology of mice with inactive insulin-like growth factor I (IGF-I). Endocr Pathol 6:382,383, 1995.
38. Michels KM, Lee WH, Seltzer A, Saavedra JM, Bondy CA. Upregulation of pituitary [125I]insulin-like growth factor-I (IGF-I) binding and IGF binding protein-2 and IGF-I gene expression by estrogen. Endocrinology 132:23-29, 1993.
39. Lara JI, Lorenzo MJ, Cacicedo L, Tolon RM, Balsa JA, Lopez-Fernandez J, Sanchez-Franco F. Induction of vasoactive intestinal peptide gene expression and prolactin secretion by insulin-like growth factor I in rat pituitary cells: evidence for an autoparacrine regulatory system. Endocrinology 135:2526-2532, 1994.
40. Kanematsu T, Irahara M, Miyake I, Shitsukawa K, Aono T. Effect of insulin-like factor I on gonadotropin release from the hypothalamus-pituitary axis in vitro. Acta Endocrinol (Copenhagen) 125:227-233, 1991.
41. Soldani R, Cagnacci A, Yen SSC. Insulin, insulin-like growth factor I (IGF-I) and IGF-II enhance basal and gonadotropin-releasing hormone-stimulated luteinizing hormone release from rat anterior pituitary cells in vitro. Eur J Endocrinol 131:641-645, 1994.
42. DeChiara TM, Efstratiadis A, Robertson EJ. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345:78-80, 1990.
43. Samaan NA, Schultz PN, Pham FK. Insulin-like growth factor II and nonsuppressible insulin-like activity levels in newborns. Am J Obstet Gynecol 163:1836-1839, 1990.
44. Verhaeghe J, Van Bree R, Van Herck E, Laureys J, Bouillon R, Van Assche FA. C-Peptide, the insulin-like growth factors-I and -II, and IGF-binding protein 1 in umbilical cord serum: correlations with birthweight. Am I Obstet Gynecol 169:89-97, 1993.
45. Gluckman PD, Barrett-Johnson JJ, Butler JH, Edgar B, Gunn TR. Studies of insulin-like growth factor I and II by specific radioligand assays in umbilical cord blood. Clin Endocrinol (Oxford) 19:405-413, 1983.
46. Lassarre C, Hardouin S, Daffos F, Forestier F, Frankenne F, Binoux M. Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationships with growth in normal subjects and in subjects with intrauterine growth retardation. Pediatr Res 29:219-225, 1991.
47. Susa JB, Widness JA, Hintz R, Liu F, Sehgal P, Schwartz R. Somatomedin and insulin in diabetic pregnancies: effects of fetal macrosomia in human and rhesus monkey. J Clin Endocrinol Metab 58:1099-1105, 1984.
48. Mesiano S, Mellon SH, Jaffe RB. Mitogenic action, regulation, and localization of insulin-like growth factors in the human fetal adrenal gland. J Clin Endocrinol Metab 76:968-976, 1993.
49. Goodyer CG, De Stephano L, Guyda HJ, Posner BI. Effects of insulin-like growth factors on adult male rat pituitary function in tissue culture. Endocrinology 115:1568-1576, 1984.
50. Goodyer CG, Marcovitz, S, Hardy J, Lefebvre Y, Guyda HJ, Posner BI. Effect of insulin-like growth factors on human foetal, adult normal and tumor pituitary function in tissue culture. Acta Endocrinol 112:49-57, 1986.
51. Simes JM, Wallace JC, Walton PK. The effects of insulin-like growth factor-I (IGF-I), IGF-II and des(1-3)IGF-I, a potent IGF analogue, on growth hormone and IGF-binding protein secretion from cultured rat anterior pituitary cells. J Endocrinol 130:93-99, 1991.
52. Ceda GP, Davis RG, Rosenfeld RG, Hoffman AR. The growth hormone (GH)-releasing hormone (GHRH)-GH-somatomedin axis: evidence for rapid inhibition of GHRH-elicited GH release by insulin-like growth factors I and II. Endocrinology 120:1658-1662, 1987.
53. Bach LA, Salemi R, Leeding KS. Roles of insulin-like growth factor (IGF) receptors and IGF-binding proteins in IGF-II-induced proliferation and differentiation of L6A1 rat myoblasts. Endocrinology 136:5061-5069, 1995.
54. Weber MM, Melmed S, Rosenbloom J, Yamasaki H, Prager D. Rat somatotroph insulin-like growth factor II (IGF-II) signaling: role of IGF-I receptor. Endocrinology 131:2147-2153, 1992.
55. Clemmons DR, Elgin RG, Han VKM, Casella SJ, D'Ercole AJ, Van Wyk JJ. Cultured fibroblast monolayers secrete a protein that alters the cellular binding of somatomedin-C/ insulin-like growth factor I. J Clin Invest 77:1548-1556, 1986.
56. Guler HP, Zapf J, Schmid C, Froesch ER. Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol 121:753-758, 1989.
57. Salmon WD Jr, DuVall MR. A serum fraction with "sulfation factor activity" stimulates in vitro incorporation of leucine and sulfate into protein-polysaccharide complexes, uridine into RNA, and thymidine into DNA of costal cartilage from hypophysectomized rats. Endocrinology 86:721-727, 1970.
58. Salmon WD Jr, DuVall MR. In vitro stimulation of leucine incorporation into muscle and cartilage protein by a serum fraction with sulfation factor activity: differentiation of effects from those of growth hormone and insulin. Endocrinology 87:1168-1180, 1970.
59. Cohen P, Fielder PJ, Hasegawa Y, Frisch H, Giudice LC, Rosenfield RG. Clinical aspects of insulin-like growth factor binding proteins. Acta Endocrinol (Copenhagen) 124(Suppl 2): 74-85, 1991.
60. Zapf J, Hauri C, Waldvogel M, Froesch ER. Acute metabolic effects and half-lives of intravenously administered insulin-like growth factor I and II in normal and hypophysectomized rats. J Clin Invest 77:1768-1775, 1986.
61. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-33, 1995.
62. Binoux M, Hossenlopp P. Insulin-like growth factor (IGF) and IGF-binding proteins: comparison of human serum and lymph. J Clin Endocrinol Metab 67:509-514, 1988.
63. Ritvos O, Ranta T, Jalkanen J, Sukkari AM, Voultilainen R, Bohn H, Rutanen EM. Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells. Endocrinology 122 :2150-2157, 1988.
64. Oh Y, Muller HL, Lamson G, Rosenfeld RG. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. J Biol Chem 268:14,964-14,971, 1993.
65. LaTour D, Mohan S, Linkhart TA, Baylink DJ, Strong DD. Inhibitory insulin-like growth factor-binding protein: cloning, complete sequence, and physiological regulation. Mol Endocrinol 4:1806-1814, 1990.
66. Elgin RG, Busby WH, Clemmons DR. An insulin-like growth factor binding protein enhances the biological response to IGF-I. Proc Natl Acad Sci USA 84:3254-3258, 1987.
67. Geary ES, Lim M, Ceda GP, Ro S, Rosenfeld RG, Hoffman AR. Tri-iodothyronine regulates insulin-like growth factor I binding to cultured rat pituitary cells. J Neuroendocrinol 1:178-184, 1989.
68. Atkin SL, Landolt AM, Jeffreys RV, Hipkin L, Radcliffe J, Square CR, White MC. Differential effects of insulin like growth factor-I on the hormonal product and proliferation of glycoprotein-secreting human pituitary adenomas. J Clin Endocrinol Metab 77:1059-1066, 1993.
69. Newton CJ, Trapp T, Pagotto U, Renner U, Buric R, Stalla GK. The oestrogen receptor modulates growth of pituitary tumour cells in the absence of exogenous oestrogen. J Mol Endocrinol 12:303-312, 1994.
70. Atkin SL, Landolt AM, Foy P, Jeffreys RV, Hipkin L, White MC. Effects of insulin-like growth factor-I on growth hormone and prolactin secretion and cell proliferation of human somatotrophinomas and prolactinomas in vitro. Clin Endocrinol 41:503-509, 1994.
71. Harris PE, Daniels M, James RA, Turner SJ, Dewar J, Kendall-Taylor P. Effects of insulin-like growth factor-II on growth hormone release from human somatotrophinoma cells in vitro. J Endocrinol 129:447-451, 1991.
72. Christofori G, Naik P, Hanahan D. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature 369:414-418, 1994.
73. Zarrilli R, Pignata S, Romano M, Gravina A, Casola S, Bruni CB, Acquaviva AM. Expression of insulin-like growth factor (IGF)-II and IGF-I receptor during proliferation and differentiation of CaCo-2 human colon carcinoma cells. Cell Growth Differentiation 5:1085-1091, 1994.
74. Kovacs K, Horvath E. Tumors of the pituitary gland. Washington, DC: Armed Forces Institute of Pathology, 1986.
75. Thapar K, Kovacs K, Laws ER. The classification and molecular biology of pituitary adenomas In: Symon et al., ed. Advance and technical standard in neurosurgery. Vol. 22. Wien: Springer-Verlag, 1995; 3-53.
76. Beilharz EJ, Bassett NS, Sirimanne ES, Williams CE, Gluckman PD. Insulin-like growth factor II is induced during wound repair following hypoxic-ischemic injury in the developing rat brain. Mol Brain Res 29:81-91, 1995.
77. Pagin JA, Brown A, Melmed S. Regulation of pituitary insulin-like growth factor-I messenger ribonucleic acid levels in rats harboring somatomammotropic tumors: implications for growth hormone autoregulation. Endocrinology 122:2204-2210, 1988.
78. Bermann M, Jaffe CA, Tsai W, DeMott-Friberg R, Barkan AL. Negative feedback regulation of pulsatile growth hormone secretion by insulin-like growth factor I. J Clin Invest 94:138-145, 1994.
79. Uchiyama T, Kaji H, Abe H, Chihara K. Negative regulation of hypothalamic growth hormone-releasing factor messenger ribonucleic acid by growth hormone and insulin-like growth factor I. Neuroendocrinology 59:441-450, 1994.
80. Sato M, Frohman LA. Differential effects of central and peripheral administration of growth hormone (GH) and insulin-like growth factor on hypothalamic GH-releasing hormone and somatostatin gene expression in GH-deficient dwarf rats. Endocrinology 133:793-799, 1993.
81. Becker K, Stegenga S, Conway S. Role of insulin-like growth factor I in regulating growth hormone release and feedback in the male rat. Neuroendocrinology 61:573-583, 1995.
82. Stefaneanu L, Kovacs K, Bartke A. In situ hybridization study of growth hormone, prolactin, and proopiomelanocortin mRNAs in adenophypophyses of mice transgenic for human growth hormone. Endocr Pathol 4:73-78, 1993.
83. Fletcher TP, Thomas GB, Dunshea FR, Moore LG, Clarke IJ. IGF feedback effects on growth hormone secretion in ewes: evidence for action at the pituitary but not the hypothalamic level. J Endocrinol 144:323-331, 1995.
84. Matsuo K, Yamashita S, Namba H, Niwa M, Harakawa S, Izumi M, Nagataki S. Modulation of pituitary insulin-like growth factor-I bindings in rats bearing somatomammotrophic tumors. J Endocrinol Invest 16:189-194, 1993.
85. Fagin JA, Fernandez-Mejia C, Melmed S. Pituitary insulin-like growth factor I gene expression: regulation by triiodothyronine and growth hormone. Endocrinology 125:2385-2391, 1989.
86. Latimer AM, Hausman GJ, McCusker RH, Buonomo FC. The effect of thyroxine on serum and tissue concentrations of insulin-like growth factors (IGF-I and-II) and IGF-binding proteins in the fetal pig. Endocrinology 133:1312-1319, 1993.
87. Frystyk J, Gronbaek H, Skjaerbaek C, Flyvbjerg A. Effect of hyperthyroidism on circulating levels of free and total IGF-I and IGFBPs in rats. Am J Physiol 265(5 Pt 1):E840-845, 1995.
88. Kim JD, Nanto-Salonen K, Szczepankiewicz JR, Rosenfeld RG, Glasscock GF. Evidence for pituitary regulation of somatic growth, insulin-like growth factors-I and -II, and their binding proteins in the fetal rat. Pediatr Res 33:144-151, 1993.
89. Turner JD, Rotwein P, Novakofski J, Bechtel PJ. Induction of mRNA for IGF-I and -II during growth hormone-stimulated muscle hypertrophy. Am J Physiol 255(4 Pt 1):E513-517, 1988.
90. Ahmed I, Lauterio TJ. Intracerebroventricular injection of insulin or glucose alters insulin-like growth factor II (IGF-II) concentrations in specific hypothalamic nuclei. Brain Res 595:242-248, 1992.
91. Lauterio TJ, Aravich PF, Rotwein P. Divergent effects of insulin on insulin-like growth factor II gene expression in rat hypothalamus. Endocrinology 126:392-398, 1990.
92. Tindall GT, Oyesiku NM, Watts NB, Clark RV, Christy JH, Adams DA. Transsphenoidal adenomectomy for growth hormone-secreting pituitary adenomas in acromegaly: outcome analysis and determinants of failure. J Neurosurg 78:205-215, 1993.
93. Pagesy P, Li JY, Kujas M, Peillon F, Delalande O, Visot A, Derome P. Apparently silent somatotroph adenomas. Pathol Res Practice 187:950-956, 1991.
94. Yamada S, Sano T, Stefaneanu L, Kovacs K, Aiba T, Sawano S, Shishiba Y. Endocrine and morphological study of a clinically silent somatotroph adenoma of the human pituitary. J Clin Endocrinol Metab 76:352-356, 1993.
95. Guler HP, Zapf J, Froesch ER. Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N Engl J Med 317:137-140, 1987.
96. Trainer PJ, Holly J, Medbak S, Rees LH, Besser GM. The effect of recombinant IGF-I on anterior pituitary function in healthy volunteers. Clin Endocrinol 41:801-807, 1994.
97. Dunger DB, Cheetham TD, Crowne EC. Insulin-like growth factors (IGFs) and IGF-I treatment in the adolescent with insulin-dependent diabetes mellitus. Metab Clin Exp 44(10 Suppl 4):119-123, 1995.
98. Laron Z, Klinger B, Erster B, Anin S. Effect of acute administration of insulin-like growth factor I in patients with Laron-type dwarfism. Lancet 2:1170-1172, 1988.